Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
作者信息
Fielding Adele K
出版信息
Haematologica. 2010 Jan;95(1):8-12. doi: 10.3324/haematol.2009.015974.
Abstract
摘要
相似文献
1
Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Haematologica. 2010 Jan;95(1):8-12. doi: 10.3324/haematol.2009.015974.
2
Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Hematology Am Soc Hematol Educ Program. 2011;2011:231-7. doi: 10.1182/asheducation-2011.1.231.
3
Philadelphia chromosome-positive Acute Lymphoblastic Leukemia.
Hematology. 2015 Dec;20(10):618-9. doi: 10.1179/1024533215Z.000000000402.
4
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Leuk Lymphoma. 2009 Dec;50 Suppl 2:9-15. doi: 10.3109/10428190903370395.
5
Tyrosine kinase inhibitor therapy or transplant in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia: striking the balance.
Lancet Haematol. 2018 Dec;5(12):e606-e607. doi: 10.1016/S2352-3026(18)30181-9.
6
7
[Outcome of autologous hematopoietic stem cell transplantation in combination with imatinib for 16 cases of Philadelphia chromosome positive acute lymphoblastic leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2014 Mar;35(3):250-2. doi: 10.3760/cma.j.issn.0253-2727.2014.03.018.
8
Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
Pediatr Blood Cancer. 2009 Jul;52(7):891-2. doi: 10.1002/pbc.21938.
9
Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument "Pro".
Clin Lymphoma Myeloma Leuk. 2017 Jul;17S:S10-S15. doi: 10.1016/j.clml.2017.03.296.
10
Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer. 2016 Oct;122(19):2941-51. doi: 10.1002/cncr.30130. Epub 2016 Jun 16.
引用本文的文献
1
Comparison of the Efficacy and Safety of Ponatinib and Dasatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia With Central Nervous System Relapse: A Retrospective Study.
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231165866. doi: 10.1177/15330338231165866.
2
How I Use Measurable Residual Disease in the Clinical Management of Adult Acute Lymphoblastic Leukemia.
Clin Hematol Int. 2021 Nov 29;3(4):130-141. doi: 10.2991/chi.k.211119.001. eCollection 2021 Dec.
3
Serological Evaluation of Anti- Antibodies in Patients with Acute Leukemia and Lymphoma through Chemotherapy.
Iran J Parasitol. 2020 Apr-Jun;15(2):187-195.
4
Preparation and Characterization of a Novel Swellable and Floating Gastroretentive Drug Delivery System (sfGRDDS) for Enhanced Oral Bioavailability of Nilotinib.
Pharmaceutics. 2020 Feb 6;12(2):137. doi: 10.3390/pharmaceutics12020137.
5
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53.
Front Oncol. 2019 Feb 18;9:57. doi: 10.3389/fonc.2019.00057. eCollection 2019.
6
Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia.
J Blood Med. 2018 Apr 13;9:67-74. doi: 10.2147/JBM.S136575. eCollection 2018.
7
Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
Cancer. 2017 Aug 1;123(15):2875-2880. doi: 10.1002/cncr.30558. Epub 2017 Apr 7.
8
Medical performance and the 'inaccessible' experience of illness: an exploratory study.
Med Humanit. 2016 Sep;42(3):186-93. doi: 10.1136/medhum-2016-010959. Epub 2016 Jul 26.
9
Transient pancytopenia preceding adult acute lymphoblastic leukemia with chromosomal abnormalities including the Philadelphia chromosome: A case report and review of the literature.
Oncol Lett. 2015 Dec;10(6):3789-3792. doi: 10.3892/ol.2015.3766. Epub 2015 Sep 29.
10
Phase II trial of hyper CVAD and dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia.
Am J Hematol. 2014 Mar;89(3):282-7. doi: 10.1002/ajh.23624.
本文引用的文献
1
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.
J Clin Oncol. 2009 Nov 1;27(31):5175-81. doi: 10.1200/JCO.2008.21.2514. Epub 2009 Oct 5.
2
Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial.
Haematologica. 2010 Jan;95(1):87-95. doi: 10.3324/haematol.2009.011221. Epub 2009 Oct 1.
3
Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors.
Blood. 2009 Sep 3;114(10):2168-71. doi: 10.1182/blood-2009-01-197186. Epub 2009 Jul 9.
4
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
Blood. 2009 May 7;113(19):4489-96. doi: 10.1182/blood-2009-01-199380. Epub 2009 Feb 24.
5
Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.
Br J Haematol. 2008 Nov;143(4):503-10. doi: 10.1111/j.1365-2141.2008.07377.x.
6
Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival.
Bone Marrow Transplant. 2009 Jan;43(2):107-13. doi: 10.1038/bmt.2008.296. Epub 2008 Sep 8.
7
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.
Blood. 2008 Aug 1;112(3):903-9. doi: 10.1182/blood-2008-03-143115. Epub 2008 Jun 2.
8
Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.
Haematologica. 2008 Feb;93(2):303-6. doi: 10.3324/haematol.11960.
9
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
Blood. 2008 Feb 15;111(4):1827-33. doi: 10.1182/blood-2007-10-116582. Epub 2007 Nov 29.
10
Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study.
Blood. 2007 Oct 1;110(7):2309-15. doi: 10.1182/blood-2007-02-073528. Epub 2007 May 11.
Zotero 插件